Key statistics
As of last trade, Hansa Biopharma AB (24H:FRA) traded at 2.70, 39.96% above the 52 week low of 1.93 set on Dec 07, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.70 |
---|---|
High | 2.70 |
Low | 2.70 |
Bid | 2.77 |
Offer | 2.95 |
Previous close | 2.51 |
Average volume | 57.56 |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.20bn SEK |
EPS (TTM) | -11.34 SEK |
Data delayed at least 15 minutes, as of Nov 14 2024 08:16 GMT.
More ▼
Press releases
- Hansa Biopharma to Attend Truist Securities BioPharma Symposium
- Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results
- Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
More ▼